GlassScriptPhysician profile
Ricky Tong
NPI 1679896112
$5,206.93
in general payments reported to CMS, 2019-2025
27 companies · $927 in 2025
The $927 reported for 2025 was more than what a typical Vascular & Interventional Radiology provider received nationally (typical 2025 total: $537).
See the full distribution for Vascular & Interventional Radiology
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $425 · 2020: $332 · 2021: $172 · 2022: $436 · 2023: $381 · 2024: $2,534 · 2025: $927.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,379 · Travel and Lodging: $1,462.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,379.49 |
| Travel and Lodging | $1,462.35 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Terumo Medical Corporation | $2,176.81 | 2021-2025 | Glidesheath Slender, Azur Cx Detachable, Hydropearl |
| Boston Scientific Corporation | $885.91 | 2019-2025 | Therasphere Administration Set, Ekosonic, Spyglass Discover |
| Inari Medical, INC. | $309.77 | 2020-2021 | |
| Penumbra, INC. | $296.88 | 2022-2025 | Ruby Coil |
| Sirtex Medical INC | $253.74 | 2019-2025 | Sir-Spheres Microspheres |
| Medtronic USA, INC. | $213.06 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $165.28 | 2023-2025 | Imfinzi, Enhertu, Calquence |
| Galvanize Therapeutics, INC | $157.77 | 2024-2025 | Aliya System |
| Medtronic, INC. | $141.64 | 2022-2025 | Kyphon Express II Kyphopak Tray, Hawkone, Concertotm |
| C. R. Bard, INC. & Subsidiaries | $107.37 | 2025 | Pleurx |
| Stryker Corporation | $96.30 | 2019-2020 | |
| Genentech USA, INC. | $45.83 | 2023 | Venclexta, Tecentriq |
| Eisai INC. | $44.02 | 2023-2024 | |
| Genzyme Corporation | $34.57 | 2023 | |
| Immunogen, INC. | $29.96 | 2024 | Elahere |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Trisalus Life Sciences, INC. | $27.79 | 2025 | Trinav Infusion System |
| Alexion Pharmaceuticals, INC. | $24.61 | 2025 | Ultomiris |
| Microvention, INC. | $23.18 | 2020 | |
| Biohaven Pharmaceutical Holding Company LTD. | $21.91 | 2022 | |
| Chiesi USA, INC. | $21.48 | 2022 | |
| Novocure INC. | $20.96 | 2025 | Optune Lua (Novottf-200t) |
| Ipsen Biopharmaceuticals, INC | $19.57 | 2024 | Onivyde |
| Biocompatibles, INC. | $18.46 | 2019 | |
| Novartis Pharmaceuticals Corporation | $18.36 | 2025 | |
| Bard Peripheral Vascular, INC. | $18.34 | 2024 | Venovo |
| Siemens Medical Solutions USA, INC. | $17.38 | 2024 | Artis Pheno |
| Janssen Pharmaceuticals, INC | $15.98 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ricky Tong listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.